Information Provided By: 
Fly News Breaks for January 30, 2020
AHCO
Jan 30, 2020 | 16:11 EDT
Stifel analyst Matthew Blackman initiated coverage of AdaptHealth with a Buy rating and $17 price target. AdaptHealth is poised to capitalize on an ongoing secular shift to home health care and "has created a foundation for continued robust revenue and profit growth" despite "what can only be described as a challenging" market, Blackman tells investors.
News For AHCO From the Last 2 Days
There are no results for your query AHCO
